Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide

Joshua Tobias(Medical University of Vienna), Ursula Wiedermann(Medical University of Vienna), Karin Baier(Medical University of Vienna), Christoph Zielinski(Vienna General Hospital), Nicholas J. Ede, Joanna Jasińska(Medical University of Vienna), Michael Kundi(Medical University of Vienna)
BMC Cancer
February 9, 2017
Cited by 44


Related Papers